About this trial
The main aim of the study is evaluate quality of life and motor performance of patients with soft tissue sarcomas undergoing surgical treatment and post-operative rehabilitation treatment.
Primary objectives:
* Identification of clinical characteristics and motor damage after surgery for soft tissue sarcomas; * Impact of perioperative treatments and surgery on the quality of life of patients with soft tissue sarcomas; * Impact of post-operative rehabilitation treatment on quality of life and recovery of motor activity The primary endpoint will be the improvement in the Toronto Extremity Salvage Score (TESS) between T1 (post-surgery) and T3 (at the end of rehabilitation treatment).
Secondary endpoints will be:
1\. the evolution over the various timepoints of the selected rating scales (Toronto Extremity Salvage Score, Musculoskeletal Tumor Society Rating Scale, Numerical Rating Scale, Brief Pain Questionnaire, Douleur Neuropathique en 4 Questions, Leeds Assessment of Neuropathic Symptoms and Signs Scale, European Organization for Research and Treatment of Cancer, Quality-of-Life Questionnaire (QLQ)-C30, Short Form Health Survey 36);
• The change in walking performance before and after the rehabilitation treatment.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with recurrent tumors;
patients with metastatic disease;
patients with palliative surgery;
patients with amputations.
Trial design
Treatments tested in this trial
- survey
Treatment groups
Sponsors and collaborators
Fondazione Policlinico Universitario Campus Bio-Medico
Lead sponsor
Fondazione Don Carlo Gnocchi Onlus
Collaborator